Co-occurring Mental Illness and Substance Use Disorders

A Guide to Diagnosis and Treatment

Featured!

  • 2018
  • 318 pages

ISBN 978-1-61537-055-9
Item #37055

$65.00

$52.00 APA Members

$48.75 APA Resident-Fellow Members

ADD TO CART

Buy in Europe

  • Description

    Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment provides a clinically detailed, evidence-based, and exhaustive examination of a topic rarely plumbed in psychiatry texts, despite the fact that co-occurring mental illness and substance use disorders are common. The authors argue for a more holistic and integrated approach, calling for clinicians to tactfully but persistently evaluate patients for a broad range of co-occurring disorders before determining appropriate treatment. Focusing on a substance use disorder in isolation, without determining whether another psychiatric disorder is co-occurring, can doom treatment efforts, and the reverse also is true. To help clinicians keep the big picture in mind, the book is organized around 18 cases, each of which addresses a particular diagnostic skill (e.g., assessment), group of disorders commonly comorbid with substance use disorders (e.g., PTSD, eating disorders), specific treatment (e.g., pharmacological interventions), or special population (e.g., adolescents). This case-based approach makes it easy for readers to understand strategies and master transferable techniques when dealing with their own patients.

    • Because the initial face-to-face sessions are especially important with this patient population, the book includes chapters on the diagnostic assessment and the initial interview, as well as offering interviewing tips throughout to help the clinician develop the necessary care and skill in this arena. Also included is a chapter on integrating motivational interviewing into the treatment.
    • Each of the 18 cases stands alone, allowing the reader flexibility in using the text. For example, the 18 cases and discussions can be read sequentially, or as needed, depending on the reader's special interest or current need.
    • The book also features chapters on how to effectively work with patients whose disorders might be affecting other members of a patient's family, since the likelihood of a successful outcome is enhanced if an integrated treatment plan is developed for their co-occurring disorders.
    • The questions that accompany each chapter can be used as an organizational tool prior to reading or to test knowledge and comprehension afterward.
    • The text is completely up-to date and provides DSM-5 diagnostic information essential to each case.

    Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment offers a straightforward approach to people with complicated presentations, offering mental health clinicians the skills they require to effectively assess, diagnose, and treat these patients and their families.

  • Contents

    Introduction
    Part 1: The Initial Interview and Comprehensive Assessment
    Chapter 1. The Initial Interview
    Chapter 2. The Comprehensive Assessment
    Part 2: Co-occurring Disorders
    Chapter 3. Depressive and Bipolar Disorders
    Chapter 4. Anxiety Disorders
    Chapter 5. Posttraumatic Stress Disorder
    Chapter 6. Psychotic Disorders
    Chapter 7. Personality Disorders
    Chapter 8. Attention-Deficit/Hyperactivity Disorder
    Chapter 9. Eating Disorders
    Chapter 10. Gambling Disorder
    Part 3: Specific Treatments
    Chapter 11. Twelve-Step Programs
    Chapter 12. Motivational Interviewing
    Chapter 13. Inpatient Treatment of Co-occurring Disorders
    Chapter 14. Pharmacological Interventions
    Part 4: Special Populations
    Chapter 15. Adolescence
    Chapter 16. Geriatrics
    Chapter 17. LGBTQ Population
    Chapter 18. Incarceration
    Appendix: Answer Guide
    Index

  • Customer Reviews
    Write a review

     
  • Editorial Reviews

    The editors of this casebook entitled, Co-Occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment provide 18 cases and discussions contributed by many major clinical researchers and practicing clinicians in addictions. These chapters form a nice set of clinical guidelines that a trainee can be read straight through or a more seasoned clinician might start with a case that sounds interesting because of a specific interest. The accompanying key points and questions with each chapter can be used to test your knowledge after you have read the chapter or to help organize your reading. Tables in each chapter are very helpful summaries of key treatment points with pharmacotherapy and specific types of psychotherapy such as Motivational Interviewing in chapter 12. Overall, this casebook is delightful reading that moves along quickly and offers insightful pointers on individualized therapy for these challenging and instructive cases. I highly recommend it for both trainees and experienced clinicians looking for new insights into treating these challenging patients.—Thomas Kosten, M.D., Waggoner Chair and Professor of Psychiatry, Neuroscience, Pharmacology, Immunology & Pathology, Baylor College of Medicine, Michael E. DeBakey VAMC, Houston, TX


    The book you are holding in your hands promises a “practical guide to complexity.” What a tall order! And yet it delivers exactly that. It is succinct, authoritative, thoroughly researched, and beautifully written.—Petros Levounis, M.D., M.A., Professor and Chair, Department of Psychiatry, Rutgers New Jersey Medical School, Chief of Service, University Hospital, Newark, NJ

  • Contributors

    Luke J. Archibald, M.D.
    Evelyn Attia, M.D.
    Maria Andrea Baez, M.D.
    Sonal Batra, M.D.
    Shannon G. Caspersen, M.D., M.Phil.
    Silvia Franco, M.D.
    Bernadine H. Han, M.D., M.S.
    Grace Hennessy, M.D.
    Rocco A. Iannucci, M.D.
    Sean P. Kerrigan, M.D.
    Zain Khalid, M.D.
    Ariel Kor, Ph.D.
    Frances R. Levin, M.D.
    Sean X. Luo, M.D., Ph.D.
    Steve Martino, Ph.D.
    Rebecca A. Nejat, M.D.
    Mayumi Okuda, M.D.
    David T. Pilkey, Ph.D.
    Richard K. Ries, M.D.
    Caitlin Snow, M.D.
    Howard R. Steinberg, Ph.D.
    J. David Stiffler, M.D.
    Lauren Stossel, M.D.
    Roger D. Weiss, M.D.
    Eric Yarbrough, M.D.
    Christine Yuodelis-Flores, M.D.
    Erin Zerbo, M.D.

  • About the Author

    Jonathan D. Avery, M.D., is Assistant Clinical Professor of Psychiatry and Assistant Dean of Student Affairs at Weill Cornell Medical College, and Assistant Attending Psychiatrist at New York-Presbyterian Hospital, Payne Whitney Clinic, in New York, New York.

    John W. Barnhill, M.D., is DeWitt Wallace Senior Scholar, Professor of Clinical Psychiatry and Medical Ethics, and Vice Chair for Psychosomatic Medicine in the Department of Psychiatry at New York Presbyterian Hospital/Weill Cornell Medicine, in New York, New York.

You May Also Like...

  • The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

    The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

  • Office-Based Buprenorphine Treatment of Opioid Use Disorder

    Office-Based Buprenorphine Treatment of Opioid Use Disorder